Literature DB >> 20981122

Chemotherapy: Effectiveness of adjuvant chemotherapy for resected NSCLC.

Martin Stuschke, Christoph Pöttgen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20981122     DOI： 10.1038/nrclinonc.2010.165

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  [Prevention, diagnosis, therapy, and follow-up of lung cancer].

Authors:  G Goeckenjan; H Sitter; M Thomas; D Branscheid; M Flentje; F Griesinger; N Niederle; M Stuschke; T Blum; K-M Deppermann; J H Ficker; L Freitag; A S Lübbe; T Reinhold; E Späth-Schwalbe; D Ukena; M Wickert; M Wolf; S Andreas; T Auberger; R P Baum; B Baysal; J Beuth; H Bickeböller; A Böcking; R M Bohle; I Brüske; O Burghuber; N Dickgreber; S Diederich; H Dienemann; W Eberhardt; S Eggeling; T Fink; B Fischer; M Franke; G Friedel; T Gauler; S Gütz; H Hautmann; A Hellmann; D Hellwig; F Herth; C P Heussel; W Hilbe; F Hoffmeyer; M Horneber; R M Huber; J Hübner; H-U Kauczor; K Kirchbacher; D Kirsten; T Kraus; S M Lang; U Martens; A Mohn-Staudner; K-M Müller; J Müller-Nordhorn; D Nowak; U Ochmann; B Passlick; I Petersen; R Pirker; B Pokrajac; M Reck; S Riha; C Rübe; A Schmittel; N Schönfeld; W Schütte; M Serke; G Stamatis; M Steingräber; M Steins; E Stoelben; L Swoboda; H Teschler; H W Tessen; M Weber; A Werner; H-E Wichmann; E Irlinger Wimmer; C Witt; H Worth
Journal:  Pneumologie       Date:  2010-03-09

Review 2.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Authors:  Anne Aupérin; Cecile Le Péchoux; Estelle Rolland; Walter J Curran; Kiyoyuki Furuse; Pierre Fournel; Jose Belderbos; Gerald Clamon; Hakki Cuneyt Ulutin; Rebecca Paulus; Takeharu Yamanaka; Marie-Cecile Bozonnat; Apollonia Uitterhoeve; Xiaofei Wang; Lesley Stewart; Rodrigo Arriagada; Sarah Burdett; Jean-Pierre Pignon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

3.  Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Lary A Robinson; John C Ruckdeschel; Henry Wagner; Craig W Stevens
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

4.  Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.

Authors:  Katherine M W Pisters; William K Evans; Christopher G Azzoli; Mark G Kris; Christopher A Smith; Christopher E Desch; Mark R Somerfield; Melissa C Brouwers; Gail Darling; Peter M Ellis; Laurie E Gaspar; Harvey I Pass; David R Spigel; John R Strawn; Yee C Ung; Frances A Shepherd
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

5.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.

Authors:  R Arriagada; A Auperin; S Burdett; J P Higgins; D H Johnson; T Le Chevalier; C Le Pechoux; M K B Parmar; J P Pignon; R L Souhami; R J Stephens; L A Stewart; J F Tierney; H Tribodet; J van Meerbeeck
Journal:  Lancet       Date:  2010-03-24       Impact factor: 79.321

6.  Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Authors:  Charles A Butts; Keyue Ding; Lesley Seymour; Philip Twumasi-Ankrah; Barbara Graham; David Gandara; David H Johnson; Kenneth A Kesler; Mark Green; Mark Vincent; Yvon Cormier; Glenwood Goss; Brian Findlay; Michael Johnston; Ming-Sound Tsao; Frances A Shepherd
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

7.  Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer.

Authors:  Rodrigo Arriagada; Ariane Dunant; Jean-Pierre Pignon; Bengt Bergman; Mariusz Chabowski; Dominique Grunenwald; Miroslaw Kozlowski; Cécile Le Péchoux; Robert Pirker; Maria-Izabel Sathler Pinel; Michèle Tarayre; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

8.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

9.  Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.

Authors:  Christoph Pöttgen; Wilfried E Eberhardt; Thomas Gauler; Thomas Krbek; Katharina Berkovic; Jehad Abu Jawad; Soenke Korfee; Helmut Teschler; Georgios Stamatis; Martin Stuschke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-07       Impact factor: 7.038

10.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  10 in total
  3 in total

1.  High Sam68 expression predicts poor prognosis in non-small cell lung cancer.

Authors:  Z Zhang; Y Xu; N Sun; M Zhang; J Xie; Z Jiang
Journal:  Clin Transl Oncol       Date:  2014-02-13       Impact factor: 3.405

2.  Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery.

Authors:  Brendan F Judy; Louis A Aliperti; Jarrod D Predina; Daniel Levine; Veena Kapoor; Philip E Thorpe; Steven M Albelda; Sunil Singhal
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

3.  SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC.

Authors:  Tao Zhang; Ningning Rong; Juan Chen; Chengwei Zou; Haiyan Jing; Xiaolong Zhu; Wenlong Zhang
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.